nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—LHCGR—Arf6 signaling events—ADRB2—chronic obstructive pulmonary disease	0.00987	0.085	CbGpPWpGaD
Goserelin—LHCGR—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.00864	0.0745	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.00709	0.0611	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.00578	0.0499	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.0049	0.0423	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.00359	0.0309	CbGpPWpGaD
Goserelin—LHCGR—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	0.00348	0.03	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00318	0.0274	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.00308	0.0265	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00273	0.0235	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.0024	0.0207	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00208	0.0179	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.002	0.0172	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00182	0.0157	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00171	0.0147	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.0017	0.0147	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00156	0.0134	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.00154	0.0133	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00153	0.0132	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00146	0.0125	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00139	0.012	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.00138	0.0119	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.00135	0.0116	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00134	0.0115	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00132	0.0114	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.0013	0.0112	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.00121	0.0104	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00117	0.0101	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00116	0.01	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00114	0.00987	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00114	0.00981	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00107	0.00918	CbGpPWpGaD
Goserelin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.0012	CcSEcCtD
Goserelin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00119	CcSEcCtD
Goserelin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00119	CcSEcCtD
Goserelin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00119	CcSEcCtD
Goserelin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00119	CcSEcCtD
Goserelin—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00118	CcSEcCtD
Goserelin—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00118	CcSEcCtD
Goserelin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00118	CcSEcCtD
Goserelin—Infection—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00118	CcSEcCtD
Goserelin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00117	CcSEcCtD
Goserelin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00117	CcSEcCtD
Goserelin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00117	CcSEcCtD
Goserelin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00117	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00103	0.00888	CbGpPWpGaD
Goserelin—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00116	CcSEcCtD
Goserelin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00116	CcSEcCtD
Goserelin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00116	CcSEcCtD
Goserelin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00116	CcSEcCtD
Goserelin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00116	CcSEcCtD
Goserelin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00116	CcSEcCtD
Goserelin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00116	CcSEcCtD
Goserelin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00116	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00102	0.00882	CbGpPWpGaD
Goserelin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00115	CcSEcCtD
Goserelin—Infection—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00115	CcSEcCtD
Goserelin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00115	CcSEcCtD
Goserelin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00115	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00102	0.00877	CbGpPWpGaD
Goserelin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00115	CcSEcCtD
Goserelin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00114	CcSEcCtD
Goserelin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00114	CcSEcCtD
Goserelin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00114	CcSEcCtD
Goserelin—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.001	0.00114	CcSEcCtD
Goserelin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000997	0.00113	CcSEcCtD
Goserelin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00099	0.00112	CcSEcCtD
Goserelin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00099	0.00112	CcSEcCtD
Goserelin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000983	0.00111	CcSEcCtD
Goserelin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00098	0.00111	CcSEcCtD
Goserelin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00098	0.00111	CcSEcCtD
Goserelin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000975	0.0011	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000974	0.0084	CbGpPWpGaD
Goserelin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000974	0.0011	CcSEcCtD
Goserelin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000971	0.0011	CcSEcCtD
Goserelin—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00097	0.0011	CcSEcCtD
Goserelin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000966	0.00109	CcSEcCtD
Goserelin—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000965	0.00109	CcSEcCtD
Goserelin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000962	0.00109	CcSEcCtD
Goserelin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000957	0.00108	CcSEcCtD
Goserelin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000957	0.00108	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000955	0.00108	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000955	0.00108	CcSEcCtD
Goserelin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000948	0.00107	CcSEcCtD
Goserelin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000948	0.00107	CcSEcCtD
Goserelin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000944	0.00107	CcSEcCtD
Goserelin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000942	0.00107	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000936	0.00106	CcSEcCtD
Goserelin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000935	0.00106	CcSEcCtD
Goserelin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000935	0.00106	CcSEcCtD
Goserelin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000932	0.00105	CcSEcCtD
Goserelin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000932	0.00105	CcSEcCtD
Goserelin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000929	0.00105	CcSEcCtD
Goserelin—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000926	0.00105	CcSEcCtD
Goserelin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000925	0.00105	CcSEcCtD
Goserelin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000923	0.00104	CcSEcCtD
Goserelin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000923	0.00104	CcSEcCtD
Goserelin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000922	0.00104	CcSEcCtD
Goserelin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000919	0.00104	CcSEcCtD
Goserelin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000913	0.00103	CcSEcCtD
Goserelin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000911	0.00103	CcSEcCtD
Goserelin—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000909	0.00103	CcSEcCtD
Goserelin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000904	0.00102	CcSEcCtD
Goserelin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000904	0.00102	CcSEcCtD
Goserelin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000904	0.00102	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000902	0.00102	CcSEcCtD
Goserelin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000896	0.00101	CcSEcCtD
Goserelin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000896	0.00101	CcSEcCtD
Goserelin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000896	0.00101	CcSEcCtD
Goserelin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000896	0.00101	CcSEcCtD
Goserelin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000895	0.00101	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000895	0.00771	CbGpPWpGaD
Goserelin—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000893	0.00101	CcSEcCtD
Goserelin—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000893	0.00101	CcSEcCtD
Goserelin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000889	0.00101	CcSEcCtD
Goserelin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000885	0.001	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000885	0.00762	CbGpPWpGaD
Goserelin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000883	0.000998	CcSEcCtD
Goserelin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00088	0.000996	CcSEcCtD
Goserelin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000878	0.000993	CcSEcCtD
Goserelin—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000878	0.000993	CcSEcCtD
Goserelin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000876	0.000991	CcSEcCtD
Goserelin—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000873	0.000987	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000872	0.00751	CbGpPWpGaD
Goserelin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000871	0.000986	CcSEcCtD
Goserelin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000869	0.000983	CcSEcCtD
Goserelin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000868	0.000982	CcSEcCtD
Goserelin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000864	0.000977	CcSEcCtD
Goserelin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000864	0.000977	CcSEcCtD
Goserelin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000863	0.000976	CcSEcCtD
Goserelin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000861	0.000973	CcSEcCtD
Goserelin—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00086	0.000973	CcSEcCtD
Goserelin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000859	0.000972	CcSEcCtD
Goserelin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000857	0.00097	CcSEcCtD
Goserelin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000857	0.00097	CcSEcCtD
Goserelin—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000857	0.000969	CcSEcCtD
Goserelin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000853	0.000965	CcSEcCtD
Goserelin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000847	0.000958	CcSEcCtD
Goserelin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000847	0.000958	CcSEcCtD
Goserelin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00084	0.00095	CcSEcCtD
Goserelin—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000839	0.00095	CcSEcCtD
Goserelin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000833	0.000942	CcSEcCtD
Goserelin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000833	0.000942	CcSEcCtD
Goserelin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000829	0.000938	CcSEcCtD
Goserelin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000829	0.000938	CcSEcCtD
Goserelin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000829	0.000938	CcSEcCtD
Goserelin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000829	0.000938	CcSEcCtD
Goserelin—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000826	0.000935	CcSEcCtD
Goserelin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000826	0.000934	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000826	0.00712	CbGpPWpGaD
Goserelin—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00082	0.000927	CcSEcCtD
Goserelin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000819	0.000927	CcSEcCtD
Goserelin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000818	0.000926	CcSEcCtD
Goserelin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000818	0.000926	CcSEcCtD
Goserelin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000816	0.000923	CcSEcCtD
Goserelin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000816	0.000923	CcSEcCtD
Goserelin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000814	0.000921	CcSEcCtD
Goserelin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000812	0.000918	CcSEcCtD
Goserelin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000812	0.000918	CcSEcCtD
Goserelin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000809	0.000916	CcSEcCtD
Goserelin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000803	0.000909	CcSEcCtD
Goserelin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000799	0.000904	CcSEcCtD
Goserelin—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000795	0.0009	CcSEcCtD
Goserelin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000786	0.00089	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000785	0.00677	CbGpPWpGaD
Goserelin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000783	0.000885	CcSEcCtD
Goserelin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000783	0.000885	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000781	0.00673	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000779	0.00671	CbGpPWpGaD
Goserelin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000772	0.000874	CcSEcCtD
Goserelin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000772	0.000874	CcSEcCtD
Goserelin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000772	0.000873	CcSEcCtD
Goserelin—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000769	0.00087	CcSEcCtD
Goserelin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000757	0.000856	CcSEcCtD
Goserelin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000752	0.000851	CcSEcCtD
Goserelin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000752	0.000851	CcSEcCtD
Goserelin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000742	0.000839	CcSEcCtD
Goserelin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000742	0.000839	CcSEcCtD
Goserelin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000737	0.000833	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000736	0.00634	CbGpPWpGaD
Goserelin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000729	0.000825	CcSEcCtD
Goserelin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000726	0.000822	CcSEcCtD
Goserelin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000717	0.000811	CcSEcCtD
Goserelin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000717	0.000811	CcSEcCtD
Goserelin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000714	0.000808	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000713	0.00615	CbGpPWpGaD
Goserelin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00071	0.000803	CcSEcCtD
Goserelin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000703	0.000795	CcSEcCtD
Goserelin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.0007	0.000792	CcSEcCtD
Goserelin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000696	0.000787	CcSEcCtD
Goserelin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000693	0.000784	CcSEcCtD
Goserelin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000693	0.000784	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00069	0.00594	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000681	0.00587	CbGpPWpGaD
Goserelin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000679	0.000768	CcSEcCtD
Goserelin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000677	0.000766	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000668	0.00576	CbGpPWpGaD
Goserelin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000668	0.000756	CcSEcCtD
Goserelin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000667	0.000754	CcSEcCtD
Goserelin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000667	0.000754	CcSEcCtD
Goserelin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000661	0.000748	CcSEcCtD
Goserelin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000661	0.000748	CcSEcCtD
Goserelin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00066	0.000747	CcSEcCtD
Goserelin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00066	0.000747	CcSEcCtD
Goserelin—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.00066	0.000747	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000658	0.00567	CbGpPWpGaD
Goserelin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000657	0.000743	CcSEcCtD
Goserelin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000657	0.000743	CcSEcCtD
Goserelin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000656	0.000742	CcSEcCtD
Goserelin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000655	0.000741	CcSEcCtD
Goserelin—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000654	0.00074	CcSEcCtD
Goserelin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000653	0.000739	CcSEcCtD
Goserelin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000647	0.000732	CcSEcCtD
Goserelin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000647	0.000732	CcSEcCtD
Goserelin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000645	0.00073	CcSEcCtD
Goserelin—Depression—Prednisone—chronic obstructive pulmonary disease	0.000645	0.00073	CcSEcCtD
Goserelin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000643	0.000728	CcSEcCtD
Goserelin—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000638	0.000721	CcSEcCtD
Goserelin—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000634	0.000717	CcSEcCtD
Goserelin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000629	0.000712	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000629	0.00542	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000629	0.00542	CbGpPWpGaD
Goserelin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000627	0.00071	CcSEcCtD
Goserelin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000624	0.000706	CcSEcCtD
Goserelin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000624	0.000705	CcSEcCtD
Goserelin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000623	0.000704	CcSEcCtD
Goserelin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000623	0.000704	CcSEcCtD
Goserelin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00062	0.000702	CcSEcCtD
Goserelin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00061	0.00069	CcSEcCtD
Goserelin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000603	0.000682	CcSEcCtD
Goserelin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000601	0.000679	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000597	0.00515	CbGpPWpGaD
Goserelin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000588	0.000665	CcSEcCtD
Goserelin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000585	0.000662	CcSEcCtD
Goserelin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000584	0.00066	CcSEcCtD
Goserelin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000581	0.000657	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000575	0.00496	CbGpPWpGaD
Goserelin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000568	0.000642	CcSEcCtD
Goserelin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000568	0.000642	CcSEcCtD
Goserelin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000559	0.000632	CcSEcCtD
Goserelin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000554	0.000627	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000553	0.00476	CbGpPWpGaD
Goserelin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000549	0.000621	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000546	0.0047	CbGpPWpGaD
Goserelin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000543	0.000614	CcSEcCtD
Goserelin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000527	0.000596	CcSEcCtD
Goserelin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000525	0.000593	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000523	0.0045	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000522	0.0045	CbGpPWpGaD
Goserelin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000519	0.000587	CcSEcCtD
Goserelin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000514	0.000581	CcSEcCtD
Goserelin—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000513	0.000581	CcSEcCtD
Goserelin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00051	0.000577	CcSEcCtD
Goserelin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000509	0.000576	CcSEcCtD
Goserelin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000506	0.000572	CcSEcCtD
Goserelin—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000506	0.000572	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000493	0.00425	CbGpPWpGaD
Goserelin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000486	0.000549	CcSEcCtD
Goserelin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000476	0.000539	CcSEcCtD
Goserelin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000469	0.000531	CcSEcCtD
Goserelin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000468	0.000529	CcSEcCtD
Goserelin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000467	0.000529	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.00046	0.00397	CbGpPWpGaD
Goserelin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000456	0.000516	CcSEcCtD
Goserelin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000451	0.00051	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000447	0.00386	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.00044	0.00379	CbGpPWpGaD
Goserelin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000438	0.000495	CcSEcCtD
Goserelin—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000436	0.000494	CcSEcCtD
Goserelin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00043	0.000487	CcSEcCtD
Goserelin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00043	0.000487	CcSEcCtD
Goserelin—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000429	0.000485	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000428	0.00369	CbGpPWpGaD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000427	0.000484	CcSEcCtD
Goserelin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000425	0.000481	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000421	0.00363	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000421	0.00363	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000419	0.00361	CbGpPWpGaD
Goserelin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000418	0.000473	CcSEcCtD
Goserelin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000413	0.000467	CcSEcCtD
Goserelin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000413	0.000467	CcSEcCtD
Goserelin—Infection—Prednisone—chronic obstructive pulmonary disease	0.00041	0.000464	CcSEcCtD
Goserelin—Shock—Prednisone—chronic obstructive pulmonary disease	0.000406	0.000459	CcSEcCtD
Goserelin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000405	0.000458	CcSEcCtD
Goserelin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000403	0.000456	CcSEcCtD
Goserelin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000401	0.000453	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.0004	0.00345	CbGpPWpGaD
Goserelin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000399	0.000451	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000395	0.0034	CbGpPWpGaD
Goserelin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000393	0.000445	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000385	0.00332	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000376	0.000425	CcSEcCtD
Goserelin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000375	0.000425	CcSEcCtD
Goserelin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000373	0.000422	CcSEcCtD
Goserelin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00037	0.000419	CcSEcCtD
Goserelin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000411	CcSEcCtD
Goserelin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000359	0.000406	CcSEcCtD
Goserelin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000358	0.000405	CcSEcCtD
Goserelin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000358	0.000405	CcSEcCtD
Goserelin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000356	0.000402	CcSEcCtD
Goserelin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000356	0.000402	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000355	0.00306	CbGpPWpGaD
Goserelin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000353	0.000399	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000353	0.00304	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.00035	0.00301	CbGpPWpGaD
Goserelin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00034	0.000385	CcSEcCtD
Goserelin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000337	0.000382	CcSEcCtD
Goserelin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000337	0.000382	CcSEcCtD
Goserelin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000328	0.000371	CcSEcCtD
Goserelin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000326	0.000369	CcSEcCtD
Goserelin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000326	0.000369	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000323	0.00278	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000321	0.00276	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000309	0.00266	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000308	0.00265	CbGpPWpGaD
Goserelin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000304	0.000344	CcSEcCtD
Goserelin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000296	0.000335	CcSEcCtD
Goserelin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000292	0.00033	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000287	0.00247	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000286	0.00247	CbGpPWpGaD
Goserelin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000282	0.000319	CcSEcCtD
Goserelin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000273	0.000309	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000264	0.00228	CbGpPWpGaD
Goserelin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000262	0.000297	CcSEcCtD
Goserelin—Rash—Prednisone—chronic obstructive pulmonary disease	0.00026	0.000294	CcSEcCtD
Goserelin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00026	0.000294	CcSEcCtD
Goserelin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000258	0.000292	CcSEcCtD
Goserelin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000245	0.000277	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000238	0.00205	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000236	0.00204	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000236	0.00203	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000225	0.00194	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000216	0.00186	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000215	0.00185	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000215	0.00185	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000207	0.00178	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000192	0.00166	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000191	0.00164	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000181	0.00156	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000172	0.00149	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000158	0.00136	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000155	0.00133	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000151	0.0013	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000144	0.00124	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000142	0.00122	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000139	0.0012	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000128	0.0011	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000121	0.00105	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000117	0.00101	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000115	0.000995	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.000107	0.000923	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000104	0.000893	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.51e-05	0.00082	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.33e-05	0.000804	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.83e-05	0.000675	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.17e-05	0.000618	CbGpPWpGaD
